Ozempic and Corticotropin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ozempic (semaglutide) and Corticotropin (corticotropin). Common drug interactions include insomnia among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Ozempic and Corticotropin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Ozempic?

Ozempic has active ingredients of semaglutide. It is often used in weight loss. eHealthMe is studying from 29,761 Ozempic users. Check the latest studies of Ozempic.

What is Corticotropin?

Corticotropin has active ingredients of corticotropin. eHealthMe is studying from 1,278 Corticotropin users. Check the latest studies of Corticotropin.



On Jul, 12, 2026

16 people who take Ozempic and Corticotropin together, and have interactions are studied.

Ozempic and Corticotropin drug interactions.

What are the common drug interactions of Ozempic and Corticotropin, by gender? *:

female:

  1. Insomnia (sleeplessness)
  2. Hyperhidrosis (abnormally increased sweating)
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Peripheral swelling
  6. Headache (pain in head)
  7. Weight increased
  8. Constipation
  9. Cough
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

male:

  1. Abdominal discomfort
  2. Abdominal distension
  3. Peripheral swelling
  4. Sinus headache (headache caused by sinus infections)
  5. Skin mass
  6. Pancreatic mass
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Dyspnoea (difficult or laboured respiration)
  9. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  10. Joint stiffness

What are the common drug interactions of Ozempic and Corticotropin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Insomnia (sleeplessness)

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Joint stiffness
  3. Limb discomfort (discomfort in leg)
  4. Lung disorder (lung disease)
  5. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  6. Dry mouth
  7. Oedema peripheral (superficial swelling)

60+:

  1. Peripheral swelling
  2. Abdominal discomfort
  3. Flatulence (flatus expelled through the anus)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Insomnia (sleeplessness)
  6. Irritability
  7. Pain
  8. Pain in extremity
  9. Salivary hypersecretion (excess saliva secretion)
  10. Synovial cyst (cyst of joint filled with synovial fluid)

What are the existing conditions these people have? *

  1. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 5 people, 31.25%
  2. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 4 people, 25.00%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 12.50%
  4. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 6.25%
  5. Pulmonary Sarcoidosis (growth of tiny collections of inflammatory cells in lungs): 1 person, 6.25%
  6. Focal Segmental Glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli): 1 person, 6.25%
  7. Diabetes Mellitus Inadequate Control: 1 person, 6.25%
  8. Diabetes: 1 person, 6.25%
  9. Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 1 person, 6.25%
  10. Cough: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ozempic and Corticotropin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ozempic and Corticotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ozempic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Corticotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ozempic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Corticotropin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on semaglutide and corticotropin (the active ingredients of Ozempic and Corticotropin, respectively), and Ozempic and Corticotropin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: